Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats

Peptides

Volumn 29, Issue 10, 2008, Pages 1726-1731

  Oliveira, P G ^a   Brenol, C V ^a,b   Edelweiss, M I ^a   Brenol, J C T ^a   Petronilho, F ^c   Roesler, R ^a   Dal Pizzol, F ^c   Schwartsmann, G ^a   Xavier, R M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Animal model; Complete Freund's adjuvant; Gastrin releasing peptide; RC 3095; Synovitis

Indexed keywords

BOMBESIN ANTAGONIST; FREUND ADJUVANT; GAMMA INTERFERON; GASTRIN ANTAGONIST; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; RC 3095; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE EROSION; CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; HYPERPLASIA; JOINT BIOPSY; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SCORING SYSTEM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BOMBESIN; FREUND'S ADJUVANT; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; PEPTIDE FRAGMENTS; PLACEBOS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, BOMBESIN; TARSUS, ANIMAL; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 52049121600     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.05.031     Document Type: Article

References (16)

1. Brenner M., Meng H.C., Yarlett N.C., Joe B., Griffiths M.M., Remmers E.F., et al. The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane-induced arthritis. J Immunol 174 12 (2005) 7894-7903
2. Cornelio D.B., Dal-Pizzol F., Roesler R., and Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18 9 (2007) 1457-1466
3. Dal-Pizzol F., Di Leone L.P., Ritter C., Martins M.R., Reinke A., Pens Gelain D., et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med 173 1 (2006) 84-90
4. Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., and Williams R. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Res Ther 5 6 (2003) R317-R328
5. Furness J.B., Kunze W.A., and Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol 277 5 Pt 1 (1999) G922-G928
6. Grimsholm O., Guo Y., Ny T., Rantapää-Dahlqvist S., and Forsgren S. Are neuropeptides important in arthritis? Studies on the importance of bombesin/GRP and substance P in a murine arthritis model. Ann N Y Acad Sci 1110 (2007) 525-538
7. Grimsholm O., Rantapaa-Dahlqvist S., and Forsgren S. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res Ther 7 3 (2005) R416-R426
8. Keeble J.E., and Brain S.D. A role for substance P in arthritis?. Neurosci Lett 361 1-3 (2004) 176-179
9. Klimiuk P.A., Yang H., Goronzy J.J., and Weyand C.M. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 90 1 (1999) 65-78
10. Larsson J., Ekblom A., Henriksson K., Lundeberg T., and Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 20 5 (1991) 326-335
11. McDonald T.J., Nilsson G., Vagne M., Ghatei M., Bloom S.R., and Mutt V. A gastrin releasing peptide from the porcine nonantral gastric tissue. Gut 19 9 (1978) 767-774
12. Ohki-Hamazaki H., Iwabuchi M., and Maekawa F. Development and function of bombesin-like peptides and their receptors. Int J Dev Biol 49 2-3 (2005) 293-300
13. Oliveira P.G., Brenol C.V., Edelweiss M.I., Meurer L., Brenol J.C., and Xavier R.M. Subcutaneous inflammation (panniculitis) in tibio-tarsal joint of rats inoculated with complete Freund's adjuvant. Clin Exp Med 7 4 (2007) 184-187
14. Schwartsmann G., DiLeone L.P., Horowitz M., Schunemann D., Cancella A., Pereira A.S., et al. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs 24 5 (2006) 403-412
15. Siddiqui M.A. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol 19 3 (2007) 308-313
16. Szepshazi K., Halmos G., Groot K., and Schally A.V. Combination treatment of nitrosamine-induced pancreatic cancers in hamsters with analogs of LH-RH and a bombesin/GRP antagonist. Int J Pancreatol 16 2-3 (1994) 141-149